Every week, RealBio® Technology hosts an interactive, web-based session to explain how this technology can benefit your research and improve your results. Attendees automatically receive an in-depth overview of the RealBio D4 ™ Culture System in advance of the session.

YES! I'd like to attend an upcoming webinar to learn more.
Name:
Organization:
Phone:
Email:
RealBio® Technology continually strives to provide the latest information on advancements in the life sciences research field. Please add me to the RealBio® Technology periodic e-mail update list so I can stay informed on these advances. Privacy Policy



News

July 30, 2014

Publication - Tissue Engineering Part C: Methods – Development of 3D Dynamic Flow Model of Human Liver and Its Application to Prediction of Metabolic Clearance of 7-Ethoxycoumarin

Read More

July 15, 2014

USPTO issued a third patent (# 8,778,330) entitled: Ex Vivo Generated Tissue System


April 6, 2014

RealBio to present Late Breaking poster at AACR 2014 in San Diego


November 2013

World CTC Congress, Boston - Roche Diagnostics to present RealBio Technology Inc data on Circulating Tumor Cells.

View File

October, 2013

RealBio closes an additional round of cash investment, lead by Covenant Healthcare.


April 8, 2013

In collaboration with Roche Molecular Systems, RealBio presents the poster entitled “In Vitro Production of Circulating Tumor Cells (CTCs) using 3D cultures of human tumor tissue” at AACR 2013 in Washington, DC.


March 25, 2013

RealBio received “2013 Innovation of the Year” Award from Michigan Celebrates Small Business.

Read More - Watch Video

March 12, 2013

United States Patent Office issues a second patent titled “Ex Vivo Generated Tissue System”: U.S. Patent # 8,494,632


March 11, 2013

In collaboration with The Hamner Institutes for Health Sciences, the poster titled “In Vitro – In Vivo Extrapolation of 7-Ethoxycoumarin Metabolism using 3D-Organotypic Liver Bioreactor” is presented at the Society of Toxicology annual meeting in San Antonio, Texas.


February 21, 2013

RealBio is awarded $40,000 through the Small Company Innovation Program (SCIP).

Read More

November 28, 2012

RealBio adds Dr. Dalia Cohn as a member of the scientific and business advisory board. Dalia is Founder and President ALN Associates.


September 19, 2012

RealBio adds Dr. Raghu Kalluri as a member of the Scientific Advisory Board. Kalluri, M.D. Ph.D. is Chair of Cancer Biology at MD Anderson in Houston, Texas.


August 2, 2012

In collaboration with a partner, RealBio expands patent landscape to include an in vitro model of metastasis.


May 31, 2012

RealBio completes a technology ‘pivot’ to focus primarily on preclinical oncology models. In addition, through the conversion of all outstanding debt into equity and the purging of non-strategic investors, the company is positioned for growth.


April 2, 2012

RealBio presents the poster entitled “Recapitulation of human tumors in vitro: Long-term culture of heterogeneous tumor cell populations in 3-dimensions” at AACR 2012.


October 17, 2011

RealBio signs a research agreement with The Hamner Institutes for Health Sciences, under the direction of Dr. Edward LeCluyse.


July 20, 2011

RealBio signs research collaboration with a large pharmaceutical / diagnostics company.


March 12, 2011

RealBioTechnology – Transforming Research & Pharmaceutical Testing

Kalamazoo – For decades, researchers and scientists could either grow cell cultures in a Petri dish or use animal subjects to generate relevant data. In vitro - or Petri dish grown cells - don’t develop the same as tissue in the human body. Tissue grown in animal subjects, called in vivo, has added costs and is not representative of the human body. RealBio Technology has changed that.

Read More - Share on LinkedIn

November 4, 2010

Healthcare reform grants going to 10 Kalamazoo drug development companies

Kalamazoo – Ten Kalamazoo companies will share more than $2.2 million in federal grant money aimed at spurring drug development and healthcare-cost savings.

Read More - Share on LinkedIn

Fall 2010

West Michigan Science & Technology Initiative

West Michigan Science & Technology Initiative – Revolutionary Research Tool Mimics Natural Micro-Environments in a Laboratory.

Read More - Share on LinkedIn

Summer 2010

Drug Discovery World

Drug Discovery World – The quarterly business review of drug discovery and development.

Read More - Share on LinkedIn

May 3, 2010

RealBio®: startup sees growth

Southwest Michigan Innovation Center – How much does a Petri dish resemble your lung? If you answered, not much, you are on the right track. For decades scientists have had limited options for using tissue cultures for research and pharmaceutical testing. They could either grow cell cultures in a Petri dish or use animal subjects.

Read More - Share on LinkedIn

April 28, 2010

Tech Tour Day Five: Serious Innovation In Kalamazoo, BC

Great Lakes Innovation and Technology Report – Paul A. Neeb, a 20-year veteran of the pharmaceutical industry, told me about RealBio® Technology, Inc., a SMIC incubator company he joined as president and CEO Jan. 1 after serving as an entrepreneur-in-residence with Southwest Michigan First, the region's economic development agency.

Read More - Share on LinkedIn

March 23, 2010

United States Patent office issues U.S. patent # 7,682,822


March 11, 2010

$250K invested in RealBio® Technology, Inc. of Kalamazoo

SW Michigan's Second Wave – Research into cell and tissue culture technology got a boost when the Biosciences Research and Commercialization Center at Western Michigan University invested $250,000 in Kalamazoo-based RealBio® Technology, Inc.

Read More - Share on LinkedIn

February 19, 2010

Cell Culture Co. RealBio® Takes $250K More For Seed Round

Down Jones VentureWire – RealBio® Technology, Inc. has received $250,000 more for a seed round that will enable it to develop its three-dimensional cell culture technology.

Read More - Share on LinkedIn

February 17, 2010

MichBio's February Michigan Biosciences LINK - RealBio® Technology Member Profile

ANN ARBOR, Michigan – RealBio® Technology, Inc., based in Kalamazoo, was formed to develop and commercialize state-of-the-art cell and tissue culture technology that facilitates the growth, expansion, differentiation and study of human and non-human cells and tissues.

Read More - Share on LinkedIn

February 2, 2010

Southwest Michigan First Life Science Fund portfolio company, RealBio® Technology, receives BRCC funding

KALAMAZOO, Michigan – The Biosciences Research and Commercialization Center (BRCC) has completed a $250,000 investment in RealBio® Technology, Inc. The BRCC, located in Western Michigan University’s Research and Technology Park, is charged with investing in and growing early stage companies in Michigan.

Read More - Share on LinkedIn

December 15, 2009

Kalamazoo companies land investments from capital fund

West Michigan Business Review – The $250,000 two Kalamazoo biotech startups each received from a state capital fund that supports technology companies will help both move farther down the road to bringing their first products to market.

Read More- Share on LinkedIn

December 8, 2009

Four Cos. Backed By Michigan Pre-Seed Capital Fund

Down Jones VentureWire – Four more Michigan companies recently received investments from the Michigan Pre-Seed Capital Fund. Combined, Mandy & Pandy, Algal Scientific Corp., Axenic Dental and RealBio® Technology received $924,000 from the fund. Individual funding totals were not provided.

Read More - Share on LinkedIn

September 30, 2009

SW Michigan Life Science Fund Invests in Startup RealBio® Technology

NEW YORK (GenomeWeb Daily News) – The Southwest Michigan First Life Science Fund said this week that it has invested an undisclosed amount in RealBio® Technology to support the commercialization of its cell and tissue culture technology for drug discovery and life science research.

Read More - Share on LinkedIn

September 29, 2009

Investments boost RealBio’s stem-cell tech

KALAMAZOO, Michigan — A Kalamazoo-based startup company received investments from three groups recently that are helping it produce technology to aid in stem-cell research.

Read More - Share on LinkedIn

September 28, 2009

Southwest Michigan First Life Science Fund invests in RealBio® Technology

KALAMAZOO, Michigan – The Southwest Michigan First Life Science Fund has announced RealBio® Technology, Inc. as the most recent addition to its portfolio.

Read More - Share on LinkedIn

September 2009

RealBio® Technology September Press Release

Read More - Share on LinkedIn

To be informed of RealBio® news and product information, click here to contact us.